Aim: The aim of this Master's program is to train professionals who can work in academic circles, health institutions, the pharmaceutical industry, or the public sector in designing, conducting, or evaluating studies on pharmaceutical economics, policy, or treatment outcomes. Due to its interdisciplinary nature, individuals working in the field of pharmacoeconomics need to have knowledge of economics, ethics, epidemiology, health system research, medicine, pharmacy, nursing, psychometrics, sociology, and statistics.
Objective: To provide understanding of socio-economic methodologies for the development of medical technologies (e.g., cost-effectiveness analysis, assessment of quality of life). To introduce techniques and use them in decision-making processes for treatment models. To evaluate the outcomes of pharmaceutical products using Markov models and mathematical simulations. To understand the structure of the health market and the forces shaping health and pharmaceutical policies. To create an environment that will stimulate a research-based environment. To provide statistical, epidemiological, and econometric training for the evaluation of therapeutic tools. To bring an understanding of the use of pharmacoeconomic and treatment outcome data in the development and maintenance of formulas and pharmaceutical policies conflicting with state and private sector policies. To provide practical experience in using databases and forward-looking work designs in the design, execution, and evaluation of pharmacoeconomic studies.
Language of Instruction: 100% English